CYDY 8-K 2026-10-19

CytoDyn Inc. (CYDY) 8-K dated 2026-10-19 — accession 0001175680-26-000038.

CytoDyn Inc. (CYDY) is a biotechnology company listed on US.

CytoDyn Inc. filed a 8-K on 2026-10-19. Accession 0001175680-26-000038.

This 8-K covers: Director/officer change (Item 5.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported CYDY revenue for 2023-05-31 was $0. Net income was -$79.8M. CYDY currently screens at market cap $367.0M.

Not investment advice. The CYDY SEC hub lists recent forms. The stock page is the research view.